## **Core Concept**
The question tests the knowledge of tumor markers associated with specific types of tumors, particularly those that are highly vascular. Tumor markers are substances produced by tumors or in response to tumors, and they can be used for diagnosis, monitoring, and sometimes treatment.

## **Why the Correct Answer is Right**
The correct answer, **.**, corresponds to **Catecholamines** or more specifically, **Metanephrines** and **Normetanephrines**, which are tumor markers for **Pheochromocytoma**. Pheochromocytomas are highly vascular tumors that arise from the adrenal glands' chromaffin cells, which produce catecholamines (adrenaline and noradrenaline). These tumors are known for their rich vascular supply, which contributes to their clinical presentation, including episodes of hypertension.

## **Why Each Wrong Option is Incorrect**
- **Option A:**. This option does not directly relate to a commonly recognized tumor marker for highly vascular tumors.
- **Option B:**. While **Calcitonin** is a tumor marker, it is primarily associated with **Medullary thyroid carcinoma**, not particularly known for being highly vascular compared to pheochromocytoma.
- **Option C:**. **CEA (Carcinoembryonic antigen)** is a tumor marker for various cancers, including colorectal, lung, and breast cancers, but it is not specifically linked to highly vascular tumors.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that pheochromocytomas are often described as the "rule of tens": 10% are bilateral, 10% are extra-adrenal (in which case they are called paragangliomas), 10% are malignant, and 10% are associated with genetic syndromes. Recognizing the association between highly vascular tumors and specific tumor markers can significantly aid in diagnosis and management.

## **Correct Answer:** . **Catecholamines**